124 related articles for article (PubMed ID: 15288160)
1. Plasma homocysteine in obstructive sleep apnoea.
Svatikova A; Wolk R; Magera MJ; Shamsuzzaman AS; Phillips BG; Somers VK
Eur Heart J; 2004 Aug; 25(15):1325-9. PubMed ID: 15288160
[TBL] [Abstract][Full Text] [Related]
2. Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover study.
McEwen BJ; Phillips CL; Morel-Kopp MC; Yee BJ; Sullivan DR; Ward CM; Tofler GH; Grunstein RR
Thromb Haemost; 2012 Oct; 108(4):701-9. PubMed ID: 22918526
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in obstructive sleep apnoea.
Svatikova A; Wolk R; Lerman LO; Juncos LA; Greene EL; McConnell JP; Somers VK
Eur Heart J; 2005 Nov; 26(22):2435-9. PubMed ID: 16105851
[TBL] [Abstract][Full Text] [Related]
4. Cysteine: a potential biomarker for obstructive sleep apnea.
Cintra F; Tufik S; D'Almeida V; Calegare BFA; de Paola A; Oliveira W; Rizzi C; Roizenblatt S; Poyares D
Chest; 2011 Feb; 139(2):246-252. PubMed ID: 20651023
[TBL] [Abstract][Full Text] [Related]
5. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J
Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
[TBL] [Abstract][Full Text] [Related]
6. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea.
Arias MA; García-Río F; Alonso-Fernández A; Hernanz A; Hidalgo R; Martínez-Mateo V; Bartolomé S; Rodríguez-Padial L
Eur Respir J; 2008 Oct; 32(4):1009-15. PubMed ID: 18508832
[TBL] [Abstract][Full Text] [Related]
7. Evening and morning blood gases in patients with obstructive sleep apnea.
Guardiola J; Yu J; Hasan N; Fletcher EC
Sleep Med; 2004 Sep; 5(5):489-93. PubMed ID: 15341895
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid a in obstructive sleep apnea.
Svatikova A; Wolk R; Shamsuzzaman AS; Kara T; Olson EJ; Somers VK
Circulation; 2003 Sep; 108(12):1451-4. PubMed ID: 12952844
[TBL] [Abstract][Full Text] [Related]
9. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study.
Phillips CL; McEwen BJ; Morel-Kopp MC; Yee BJ; Sullivan DR; Ward CM; Tofler GH; Grunstein RR
Thorax; 2012 Jul; 67(7):639-44. PubMed ID: 22334531
[TBL] [Abstract][Full Text] [Related]
10. Obstructive sleep apnea and aldosterone.
Svatikova A; Olson LJ; Wolk R; Phillips BG; Adachi T; Schwartz GL; Somers VK
Sleep; 2009 Dec; 32(12):1589-92. PubMed ID: 20041594
[TBL] [Abstract][Full Text] [Related]
11. Serum urate and obstructive sleep apnoea in severe obesity.
Seetho IW; Parker RJ; Craig S; Duffy N; Hardy KJ; Wilding JP; Goodson NJ
Chron Respir Dis; 2015 Aug; 12(3):238-46. PubMed ID: 25990129
[TBL] [Abstract][Full Text] [Related]
12. Diurnal variation of circulating microvesicles is associated with the severity of obstructive sleep apnoea.
Bikov A; Kunos L; Pállinger É; Lázár Z; Kis A; Horváth G; Losonczy G; Komlósi ZI
Sleep Breath; 2017 Sep; 21(3):595-600. PubMed ID: 28130736
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: an observational study.
Anandam A; Patil M; Akinnusi M; Jaoude P; El-Solh AA
Respirology; 2013 Nov; 18(8):1184-90. PubMed ID: 23731062
[TBL] [Abstract][Full Text] [Related]
14. Evidence for lipid peroxidation in obstructive sleep apnea.
Lavie L; Vishnevsky A; Lavie P
Sleep; 2004 Feb; 27(1):123-8. PubMed ID: 14998248
[TBL] [Abstract][Full Text] [Related]
15. [Plasma homocysteine levels in ischemic stroke patients with obstructive sleep apnea].
Chen MG; Zhu WS; Yin Q; Wu BN; Wang QZ; Ma MM; Liu DZ; Li YK; Liu CL; Huang XJ; Chen ZY; Wang WX; Xu GL; Liu XF
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(25):1753-6. PubMed ID: 22093733
[TBL] [Abstract][Full Text] [Related]
16. Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy.
Henley DE; Buchanan F; Gibson R; Douthwaite JA; Wood SA; Woltersdorf WW; Catterall JR; Lightman SL
J Endocrinol; 2009 Oct; 203(1):181-8. PubMed ID: 19643928
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?
Lefebvre B; Pépin JL; Baguet JP; Tamisier R; Roustit M; Riedweg K; Bessard G; Lévy P; Stanke-Labesque F
Eur Respir J; 2008 Jul; 32(1):113-20. PubMed ID: 18321935
[TBL] [Abstract][Full Text] [Related]
18. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure.
Ip MS; Lam B; Chan LY; Zheng L; Tsang KW; Fung PC; Lam WK
Am J Respir Crit Care Med; 2000 Dec; 162(6):2166-71. PubMed ID: 11112132
[TBL] [Abstract][Full Text] [Related]
19. Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep Apnea.
Thunström E; Manhem K; Rosengren A; Peker Y
Am J Respir Crit Care Med; 2016 Feb; 193(3):310-20. PubMed ID: 26414380
[TBL] [Abstract][Full Text] [Related]
20. Plasma renin levels and renin-blood pressure relationship in normal-weight and overweight children with obstructive sleep apnea and matched controls.
Shamsuzzaman A; Szczesniak RD; Fenchel MC; Amin RS
Sleep Med; 2015 Jan; 16(1):101-6. PubMed ID: 25488600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
